The upcoming session, hosted by Xtalks on July 22, 2026, features a panel of experts including Alessandra Grossi of TransPerfect Life Sciences and representatives from uniQure, Theramex, and Biocon Biologics. The discussion centers on the friction points where departmental boundaries blur, specifically focusing on how safety signals are escalated and how teams manage complex inquiries involving off-label use.
In section Releases
Bridging Silos in Medical Information and Regulatory Affairs
When a safety signal surfaces in a medical inquiry, the speed of response depends on the invisible handoffs between Medical Information, Pharmacovigilance, and Regulatory Affairs. As these departments face increasing pressure to maintain labeling consistency, a new industry webinar aims to standardize cross-functional collaboration during high-stakes safety crises.
Beyond traditional communication strategies, the panel will address the integration of AI and automation into these workflows. While these technologies offer potential for faster signal detection and streamlined labeling updates, they require robust governance frameworks to remain compliant. Attendees will receive practical guidance on avoiding common decision-making pitfalls and building the internal structures necessary for cohesive, rapid crisis management.
Comments (0)
No comments yet. Be the first!